2003
DOI: 10.1016/s0028-3908(03)00040-6
|View full text |Cite
|
Sign up to set email alerts
|

Generalization of clozapine as compared to other antipsychotic agents to a discriminative stimulus elicited by the serotonin (5-HT)2A antagonist, MDL100,907

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
12
0

Year Published

2004
2004
2011
2011

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(13 citation statements)
references
References 43 publications
1
12
0
Order By: Relevance
“…This suggests the possibility that the 5-HT 2A antagonist properties of M100907 may not have been responsible for the CLZappropriate responding in the present study. While not as potent at other receptors, M100907 does bind to 5HT 2C , D 2 , and α 1 receptors (Dekeyne et al 2003). Also, ritanserin is an antagonist at both 5-HT 2A and 5-HT 2C receptors.…”
Section: Discussionmentioning
confidence: 88%
See 3 more Smart Citations
“…This suggests the possibility that the 5-HT 2A antagonist properties of M100907 may not have been responsible for the CLZappropriate responding in the present study. While not as potent at other receptors, M100907 does bind to 5HT 2C , D 2 , and α 1 receptors (Dekeyne et al 2003). Also, ritanserin is an antagonist at both 5-HT 2A and 5-HT 2C receptors.…”
Section: Discussionmentioning
confidence: 88%
“…Fluoxetine does not display any significant occupancy of 5-HT 2A receptors, although it does display up to 43% occupancy of 5-HT 2C receptors at a 20 mg/kg dose (Palvimaki et al 1999). Also, it should be noted that Dekeyne et al (2003) trained rats to discriminate the 5-HT 2A antagonist M100907 and reported that the atypical APDs CLZ, quetiapine, risperidone, and ziprasidone all The atypical APD melperone substituted for CLZ, but has a lower affinity for 5-HT 2A receptors than do the other APDs discussed above. It does display a preferential ratio for 5-HT 2A receptors relative to D 2 receptors, as do all of the atypical APDs that fully substituted for CLZ in the present study (and in the Philibin et al 2005 study).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…For reviews of drug discrimination studies in which antipsychotic drugs have been tested for their ability to block the discriminative stimulus properties of other training drugs (like low-dose amphetamine discrimination, DOI discrimination, and MK-801 discrimination) see Arnt and Skarsfeldt (1998) and Goudie and Smith (1999). In addition, the present review did not attempt to review the discriminative stimulus properties of putative antipsychotic drugs such as MDL 100,907 (Dekeyne et al 2003) or S 16924 (Millan et al 1998(Millan et al , 1999.…”
Section: Introductionmentioning
confidence: 99%